Stocks and Investing Stocks and Investing
Wed, May 11, 2011

INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART), Up By 5.46% ($2.74) From $50.160 After BUYINS.NET Report Predicted Strength After E


Published on 2011-05-11 08:13:27 - WOPRAI
  Print publication without navigation


May 11, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, April 27th 2011 stating that INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) was expected to be Up After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=iart&id=163139

At the time this story was written, INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is Up By 5.46% ($2.74) From $50.160 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) - Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, orthopedics, and general surgery primarily in the United States, Europe, and the Asia Pacific. Its orthopedics product portfolio comprises dermal regeneration and engineered wound dressings to treat the chronic wounds; nerve and tendon for the peripheral nerve repair and protection; bone and joint fixation devices and instruments for upper and lower extremity reconstruction; and bone graft substitutes for extremity reconstruction. The companys spine and orthobiologics product portfolio includes spinal fusion devices for fusing two vertebrae; supplemental fixation systems for cervical procedures; interbody/vertebral body replacement devices to hold the graft in place to ensure a fusion; orthobiologic products for the repair and regeneration of bone in spinal and trauma surgery; and minimally invasive spine products. Integras neurosciences product portfolio includes duraplasty products for managing dural defects; tissue ablation equipment for the ablation of unwanted tissue; cerebral spinal fluid management devices for managing the intracranial pressure of a neuro-compromised patient; cranial stabilization equipment for fixing the head in an orientation determined by the surgeon; and intracranial monitoring equipment for monitoring intracranial pressure and metabolic activity. Its medical instruments product portfolio comprises room instrumentation and surgical lighting; and hand-held surgical instruments for the surgical, dental, podiatry, and animal health markets. The company sells its products directly through various sales forces and other distribution channels. Integra was founded in 1989 and is headquartered in Plainsboro, New Jersey.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources